Results 131 to 140 of about 5,221 (170)

Esketamine

2023
openaire   +1 more source

Neurocognitive aspects of ketamine and esketamine on subjects with treatment-resistant depression: A comparative, randomized and double-blind study

Psychiatry Research, 2021
Gustavo Carneiro-Gomes Leal, Flavia Vieira, Ana Paula De Jesus Nunes   +2 more
exaly  

Clinical effects of low‐dose esketamine for anaesthesia induction in the elderly: A randomized controlled trial

Journal of Clinical Pharmacy and Therapeutics, 2022
Juan Li
exaly  

Hydrogel-forming microneedle arrays as a therapeutic option for transdermal esketamine delivery

Journal of Controlled Release, 2020
Lalitkumar K Vora, Ryan F Donnelly, Helen Mccarthy   +2 more
exaly  

Esketamine

Reactions Weekly, 2017
openaire   +1 more source

Long-term safety of ketamine and esketamine in treatment of depression

Expert Opinion on Drug Safety, 2022
John Krystal, Sina Nikayin, Samuel Wilkinson   +2 more
exaly  

The antidepressant effect and safety of non-intranasal esketamine: A systematic review

Journal of Psychopharmacology, 2022
Marije Aan Het Rot, Sanne Smith-Apeldoorn, Robert Schoevers   +2 more
exaly  

Esketamine

Reactions Weekly, 2018
openaire   +1 more source

Escitalopram/esketamine

Reactions Weekly, 2022
openaire   +1 more source

Intravenous Esketamine in Adult Treatment-Resistant Depression: A Double-Blind, Double-Randomization, Placebo-Controlled Study

Biological Psychiatry, 2016
Pascal Sienaert, Geert De Bruecker, Husseini Manji   +2 more
exaly